Nanoparticles can be engineered to interact with the nucleus in several ways. They can be designed to pass through the cell membrane and nuclear envelope to deliver drugs, genes, or other therapeutic agents directly to the nucleus. This can be achieved by functionalizing nanoparticles with specific ligands that recognize and bind to nuclear receptors, facilitating targeted delivery.
